Progress In Personalized Medicine Is Slower Than Some Had Expected, Partly Because Of The Science And Partly Because Of Insufficient Economic Incentives, Particularly For Investing In Molecular Diagnostics (MDX)
Mallinson, M.Volume:
17
Langue:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.03.083
Date:
May, 2014
Fichier:
PDF, 60 KB
english, 2014